4.3 Article

Lower verbal intelligence is associated with diabetic complications and slower walking speed in people with Type 2 diabetes: the Maastricht Study

Journal

DIABETIC MEDICINE
Volume 33, Issue 12, Pages 1632-1639

Publisher

WILEY
DOI: 10.1111/dme.13105

Keywords

-

Funding

  1. European Regional Development Fund via OP-Zuid
  2. Province of Limburg
  3. Dutch Ministry of Economic Affairs [31O.041]
  4. Stichting De Weijerhorst (Maastricht, the Netherlands)
  5. Pearl String Initiative Diabetes (Amsterdam, the Netherlands)
  6. Cardiovascular Center (CVC, Maastricht, the Netherlands)
  7. Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands)
  8. School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands)
  9. School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands)
  10. Stichting Annadal (Maastricht, the Netherlands)
  11. Health Foundation Limburg (Maastricht, the Netherlands)
  12. Janssen-Cileg B.V. (Tilburg, the Netherlands)
  13. Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands)
  14. Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)

Ask authors/readers for more resources

AimsTo determine the association of verbal intelligence, a core constituent of health literacy, with diabetic complications and walking speed in people with Type 2 diabetes. MethodsThis study was performed in 228 people with Type 2 diabetes participating in the Maastricht Study, a population-based cohort study. We examined the cross-sectional associations of score on the vocabulary test of the Groningen Intelligence Test with: 1) determinants of diabetic complications (HbA(1c), blood pressure and lipid level); 2) diabetic complications: chronic kidney disease, neuropathic pain, self-reported history of cardiovascular disease and carotid intima-media thickness; and 3) walking speed. Analyses were performed using linear regression and adjusted in separate models for potential confounders and mediators. Significant age- and sex-adjusted associations were additionally adjusted for educational level in a separate model. ResultsAfter full adjustment, lower verbal intelligence was associated with the presence of neuropathic pain [odds ratio (OR) 1.18, 95% CI 1.02;1.36], cardiovascular disease (OR 1.14, 95% CI 1.01;1.30), and slower walking speed (regression coefficient -0.011 m/s, 95% CI -0.021; -0.002 m/s). These associations were largely explained by education. Verbal intelligence was not associated with blood pressure, glycaemic control, lipid control, chronic kidney disease or carotid intima-media thickness. ConclusionsLower verbal intelligence was associated with the presence of some diabetic complications and with a slower walking speed, a measure of physical functioning. Educational level largely explained these associations. This implies that clinicians should be aware of the educational level of people with diabetes and should provide information at a level of complexity tailored to the patient.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial

Mathias D. G. Van den Eynde, Alfons J. H. M. Houben, Jean L. J. M. Scheijen, Armand M. A. Linkens, Petra M. Niessen, Nynke Simons, Nordin M. J. Hanssen, Yvo H. A. M. Kusters, Simone J. M. P. Eussen, Toshio Miyata, Coen D. A. Stehouwer, Casper G. Schalkwijk

Summary: This study found that pyridoxamine (PM), a B6 vitamer and dicarbonyl scavenger, can reduce methylglyoxal (MGO), protein-bound N delta-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1). However, PM does not affect insulin sensitivity and vascular function.

DIABETES OBESITY & METABOLISM (2023)

Article Multidisciplinary Sciences

Device-measured sitting time and musculoskeletal pain in adults with normal glucose metabolism, prediabetes and type 2 diabetes-The Maastricht Study

Francis Q. S. Dzakpasu, Annemarie Koster, Neville Owen, Bastiaan E. de Galan, Alison Carver, Christian J. Brakenridge, Annelies Boonen, Hans Bosma, Pieter C. Dagnelie, Simone J. P. M. Eussen, Parneet Sethi, Coen D. A. Stehouwer, Nicolaas C. Schaper, David W. Dunstan

Summary: This study found a significant association between daily sitting time and knee pain in middle-aged and older adults with type 2 diabetes. However, no significant association was observed between sitting time and neck, shoulder, or low back pain in any of the models. Further studies are needed to examine the relationship between sitting time and different types of pain, as well as other aspects of sedentary behavior.

PLOS ONE (2023)

Article Endocrinology & Metabolism

The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus

Veerle van Hulten, Johanna H. M. Driessen, Jakob K. Starup-Linde, Zheer K. Al-Mashhadi, Rikke Viggers, Olaf H. Klungel, Patrick C. Souverein, Peter Vestergaard, Coen D. A. Stehouwer, Joop P. van den Bergh

Summary: A study compared the use of SGLT2 inhibitors and DPP-4 inhibitors as add-on to metformin and found no significant difference in the risk of fractures or major osteoporotic fractures between the two groups.

DIABETES OBESITY & METABOLISM (2023)

Review Endocrinology & Metabolism

Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review

Vivienne Chuter, Nicolaas Schaper, Joseph Mills, Robert Hinchliffe, David Russell, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, Jos C. van den Berg, Maarit Venermo, Robert Fitridge

Summary: Early diagnosis and ongoing monitoring and treatment of peripheral artery disease (PAD) is crucial for reducing the risk of foot ulcer development, non-healing of wounds, infection, amputation, and cardiovascular complications in patients with diabetes. Various non-invasive bedside tests are available for diagnosing PAD, but the most accurate test and its reliability for ongoing monitoring are still uncertain. This systematic review aimed to determine the diagnostic accuracy of non-invasive bedside tests for identifying PAD and their reliability in adults with diabetes. The review included 40 studies on diagnostic accuracy and 7 studies on reliability. Ankle-brachial index (ABI) was the most investigated test. The review found that an ABI <0.9 increases the likelihood of disease, while an ABI within the normal range (≥0.90 and <1.3) does not exclude PAD. Toe-brachial index (TBI) and Doppler waveforms in the pedal arteries were also associated with PAD presence. Several bedside tests showed acceptable reliability, but the margin of error was wide. No single or combination of bedside tests demonstrated superior diagnostic accuracy for PAD in patients with diabetes. However, an ABI of 1.3, TBI <0.70, and absent or monophasic pedal Doppler waveforms can help identify the presence of disease.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Endocrinology & Metabolism

Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review

Vivienne Chuter, Nicolaas Schaper, Robert Hinchliffe, Joseph Mills, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, Russell David, Jos C. van den Berg, Maarit Venermo, Robert Fitridge

Summary: This systematic review aimed to determine the performance of non-invasive bedside tests for predicting the outcomes of DFU healing, minor amputation, and major amputation in people with diabetes and DFU or gangrene. The results showed that a toe pressure of ≥30 mmHg, TcPO2 of ≥25 mmHg, and skin perfusion pressure of ≥40 mmHg were associated with a moderate to large increase in the likelihood of DFU healing. However, there is limited research on the prognostic capacity of bedside testing for healing post-minor amputation or major amputation in people with DFU. Current evidence suggests that an ABI <0.4 may be associated with a large increase in the risk of major amputation.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study

Sara B. A. Mokhtar, Frank C. T. van der Heide, Karel A. M. Oyaert, Carla J. H. van der Kallen, Tos T. J. M. Berendschot, Fabio Scarpa, Alessia Colonna, Bastiaan E. de Galan, Marleen M. J. van Greevenbroek, Pieter C. Dagnelie, Casper G. Schalkwijk, Rudy M. M. A. Nuijts, Nicolaas C. Schaper, Abraham A. Kroon, Miranda T. Schram, Carroll A. B. Webers, Coen D. A. Stehouwer

Summary: This study used population-based observational cross-sectional data to assess the associations between glucose metabolism status and measures of glycaemia with corneal nerve fibre measures. The results showed a linear association between adverse glucose metabolism status, higher levels of glycaemic measures, and corneal neurodegeneration. This study provides evidence that hyperglycaemia-associated corneal neurodegeneration is a continuous process that occurs before the onset of type 2 diabetes.

DIABETOLOGIA (2023)

Article Multidisciplinary Sciences

Quantifying postprandial glucose responses using a hybrid modeling approach: Combining mechanistic and data-driven models in The Maastricht Study

Balazs Erdos, Bart van Sloun, Gijs H. Goossens, Shauna D. O'Donovan, Bastiaan E. de Galan, Marleen M. J. van Greevenbroek, Coen D. A. Stehouwer, Miranda T. Schram, Ellen E. Blaak, Michiel E. Adriaens, Natal A. W. van Riel, Ilja C. W. Arts

Summary: The combination of mechanistic and data-driven modeling approaches is explored in studying individual glucose regulation, and personalized mechanistic models are found to outperform data-driven models in predicting glucose and insulin responses.

PLOS ONE (2023)

Article Clinical Neurology

Both short and long sleep durations are associated with type 2 diabetes, independent from traditional lifestyle risk factors-The Maastricht Study

Jeroen D. Albers, Ree M. Meertens, Hans H. C. M. Savelberg, Sebastian Kohler, Anke Wesselius, Miranda T. Schram, Coen D. A. Stehouwer, Bastiaan E. de Galan, Marleen M. J. van Greevenbroek, Carla J. H. van der Kallen, Simone J. P. M. Eussen, Hans Bosma, Nicolaas C. Schaper, Annemarie Koster

Summary: There is a U-shaped association between sleep duration and type 2 diabetes, where both short and long sleep durations are independently and positively correlated with type 2 diabetes, but not with prediabetes.

SLEEP HEALTH (2023)

Article Gastroenterology & Hepatology

Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study

Zhewen Ren, Hans Bosma, Anke Wesselius, Simone J. P. M. Eussen, M. Eline Kooi, Carla J. H. van der Kallen, Annemarie Koster, Marleen M. J. van Greevenbroek, Pieter Dagnelie, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers

Summary: Individuals with lower socioeconomic position have higher intrahepatic lipid content compared to those with higher socioeconomic position, which may be attributed to unhealthy lifestyle factors such as reduced physical activity and higher intake of sugar sweetened beverages. However, other yet unknown factors may also play a role.

JHEP REPORTS (2023)

Meeting Abstract Ophthalmology

(Pre) diabetes and a higher level of glycemia are continuously associated with corneal neurodegeneration-The Maastricht Study

S. B. A. Mokhtar, F. C. T. van der Heide, K. A. M. Oyaert, C. J. H. van der Kallen, T. T. J. M. Berendschot, F. Scarpa, A. Colonna, B. E. de Galan, M. M. J. van Greevenbroek, C. G. Schalkwijk, R. M. M. A. Nuijts, M. T. Schram, C. A. B. Webers, C. D. A. Stehouwer

ACTA OPHTHALMOLOGICA (2023)

Meeting Abstract Endocrinology & Metabolism

Bone Microarchitecture and Strength Assessed by HR-pQCT in Individuals With Normal Glucose Metabolism and Type 2 Diabetes: The Maastricht Study

Veerle van Hulten, Cindy Sarodnik, Johanna Driessen, Sandrine Bours, Nicklas Rasmussen, Rikke Viggers, Nicolaas Schaper, Annemarie Koster, Marleen van Greevenbroek, Carla van der Kallen, Coen Stehouwer, Joop van den Bergh

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Hematology

Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study

B. Wauben, M. W. M. van der Poel, M. M. J. Greevenbroek, N. C. van Yperen, M. T. Schram, M. P. J. van Boxtel, M. Sastry, S. O. Simons, C. D. A. Stehouwer, P. C. Dagnelie, A. Wesselius, H. C. Schouten, S. Kohler

Summary: Although cognitive problems can recover over time, a subgroup of hematopoietic stem cell transplantation (HCT) survivors experience persistent cognitive problems in the long term. The aim of this study was to quantify the prevalence of cognitive impairment in HCT survivors and identify potential determinants of cognitive functioning within this group. Cognitive performance was assessed using a neuropsychological test battery divided into three domains: memory, information processing speed, and executive function and attention.

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Article Geriatrics & Gerontology

Association of type 2 diabetes according to the number of risk factors within the recommended range with incidence of major depression and clinically relevant depressive symptoms: a prospective analysis

April C. E. van Gennip, Miranda Schram, Sebastian Kohler, Abraham A. Kroon, Annemarie Koster, Simone J. P. M. Eussen, Bastiaan E. de Galan, Thomas T. van Sloten, Coen D. A. Stehouwer

Summary: This study examined the incidence of major depression and clinically relevant depressive symptoms among individuals with type 2 diabetes, based on the number of risk factors within the recommended target range. The study found that the risk of depression decreased stepwise with an increasing number of risk factors within the recommended target range in individuals with type 2 diabetes. Therefore, this study provides evidence to promote risk factor modification strategies and the adoption of a healthy lifestyle in individuals with type 2 diabetes.

LANCET HEALTHY LONGEVITY (2023)

No Data Available